Ensysce Biosciences, Inc.

NasdaqCM:ENSC Stock Report

Market Cap: US$11.6m

Ensysce Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ENSC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders174,9450.894%
Institutions275,4171.41%
Hedge Funds2,146,11011%
VC/PE Firms2,776,00014.2%
General Public14,201,54272.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 522.2%.

Top Shareholders

Top 20 shareholders own 27.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.54%
RA Capital Management, L.P.
1,476,000US$874.4k0%0.01%
6.64%
Perceptive Advisors LLC
1,300,000US$770.1k0%0.02%
5.94%
Sabby Management, LLC
1,162,592US$688.7k270%7.67%
5.02%
Anson Group
983,518US$582.6k0%0.09%
0.62%
Robert Gower
121,890US$72.2k0%no data
0.58%
UBS Asset Management AG
112,682US$66.8k0%no data
0.24%
Geode Capital Management, LLC
46,072US$27.3k-0.06%no data
0.16%
Hui-Chung Chang
31,231US$18.5k0%no data
0.12%
Citadel Advisors LLC
23,605US$14.0k-72.7%no data
0.12%
Hudson River Trading LLC, Asset Management Arm
23,558US$14.0k0%no data
0.11%
Renaissance Technologies LLC
22,400US$13.3k0%no data
0.11%
Cerity Partners LLC
21,426US$12.7k0%no data
0.1%
Andrew Benton
20,025US$11.9k0%no data
0.093%
The Vanguard Group, Inc.
18,175US$10.8k0%no data
0.033%
Tower Research Capital Europe Limited
6,454US$3.8k-21.8%no data
0.0081%
D. Kirkpatrick
1,591US$942.70%no data
0.005%
BlackRock, Inc.
975US$577.50%no data
0.0011%
David Humphrey
208US$122.90%no data
0.00035%
Bank of America Corporation, Asset Management Arm
69US$40.611.3%no data
0.00001%
Strategic Advisers LLC
1US$1.20%no data